Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Tissue Biomarkers in Predicting Response to Sunitinib Treatment of Metastatic Renal Cell Carcinoma

IVAN TRÁVNÍČEK, JINDŘICH BRANŽOVSKÝ, KRISTÝNA KALUSOVÁ, ONDŘEJ HES, LUBOŠ HOLUBEC, KEVIN BAULETH PELE, TOMÁŠ ÜRGE and MILAN HORA
Anticancer Research October 2015, 35 (10) 5661-5666;
IVAN TRÁVNÍČEK
1Department of Urology, Faculty Hospital in Pilsen, Pilsen, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: travniceki@fnplzen.cz
JINDŘICH BRANŽOVSKÝ
2Department of Pathology, Faculty Hospital in Pilsen, Pilsen, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KRISTÝNA KALUSOVÁ
1Department of Urology, Faculty Hospital in Pilsen, Pilsen, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ONDŘEJ HES
2Department of Pathology, Faculty Hospital in Pilsen, Pilsen, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LUBOŠ HOLUBEC
3Department of Oncology and Radiotherapy, Faculty Hospital in Pilsen, Pilsen, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KEVIN BAULETH PELE
2Department of Pathology, Faculty Hospital in Pilsen, Pilsen, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMÁŠ ÜRGE
1Department of Urology, Faculty Hospital in Pilsen, Pilsen, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MILAN HORA
1Department of Urology, Faculty Hospital in Pilsen, Pilsen, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 35 no. 10 5661-5666
PubMed 
26408740

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received June 3, 2015
  • Revision received July 23, 2015
  • Accepted July 24, 2015
  • Published online September 25, 2015.

Copyright & Usage 
Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. IVAN TRÁVNÍČEK1⇑,
  2. JINDŘICH BRANŽOVSKÝ2,
  3. KRISTÝNA KALUSOVÁ1,
  4. ONDŘEJ HES2,
  5. LUBOŠ HOLUBEC3,
  6. KEVIN BAULETH PELE2,
  7. TOMÁŠ ÜRGE1 and
  8. MILAN HORA1
  1. 1Department of Urology, Faculty Hospital in Pilsen, Pilsen, Czech Republic
  2. 2Department of Pathology, Faculty Hospital in Pilsen, Pilsen, Czech Republic
  3. 3Department of Oncology and Radiotherapy, Faculty Hospital in Pilsen, Pilsen, Czech Republic
  1. Correspondence to: Ivan Trávníček, MD, Department of Urology, Faculty Hospital, E. Beneše 13, 305 99 Plzeň, Czech Republic. E-mail: travniceki{at}fnplzen.cz
View Full Text

Cited By...

  • 5 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Anticancer Research: 35 (10)
Anticancer Research
Vol. 35, Issue 10
October 2015
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tissue Biomarkers in Predicting Response to Sunitinib Treatment of Metastatic Renal Cell Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
13 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Tissue Biomarkers in Predicting Response to Sunitinib Treatment of Metastatic Renal Cell Carcinoma
IVAN TRÁVNÍČEK, JINDŘICH BRANŽOVSKÝ, KRISTÝNA KALUSOVÁ, ONDŘEJ HES, LUBOŠ HOLUBEC, KEVIN BAULETH PELE, TOMÁŠ ÜRGE, MILAN HORA
Anticancer Research Oct 2015, 35 (10) 5661-5666;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Tissue Biomarkers in Predicting Response to Sunitinib Treatment of Metastatic Renal Cell Carcinoma
IVAN TRÁVNÍČEK, JINDŘICH BRANŽOVSKÝ, KRISTÝNA KALUSOVÁ, ONDŘEJ HES, LUBOŠ HOLUBEC, KEVIN BAULETH PELE, TOMÁŠ ÜRGE, MILAN HORA
Anticancer Research Oct 2015, 35 (10) 5661-5666;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Estimating the Survival of Elderly Patients with Renal Cell Carcinoma Presenting with Malignant Spinal Cord Compression
  • Google Scholar

More in this TOC Section

  • Effect of Postoperative Muscle Loss After Resection of Non-small Cell Lung Cancer on Surgical Outcomes
  • The Prognostic Relevance of Preoperative CEA and CA19-9 for Ampulla of Vater Carcinoma
  • Difference in the Overall Survival Between Malignant Central Airway Obstruction Patients Treated by Transbronchial Microwave Ablation and Stent Placement: A Single-institution Retrospective Study
Show more Clinical Studies

Similar Articles

Keywords

  • Metastatic renal carcinoma
  • targeted-therapy
  • prediction
  • Biomarkers
  • immunohistochemistry
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire